• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Suanfarma, at the Core of a Better Life.

    Senaparib Approved By NMPA For Ovarian Cancer Maintenance Therapy

    PR NEWSWIRE

    Junshi Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.